• 1. Department of Thoracic Surgery, China-Japan Friendship School of Clinical Medicine, Peking University, Beijing, 100029, P. R. China;
  • 2. Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, 100029, P. R. China;
LIANG Chaoyang, Email: chaoyangliang@zryhyy.com
Export PDF Favorites Scan Get Citation

Objective  To investigate the clinical characteristics, surgical strategies, antifungal therapy, and outcomes of patients with pulmonary mucormycosis who underwent surgical treatment. Methods  We retrospectively included patients with an etiologically confirmed diagnosis of pulmonary mucormycosis who were admitted to and underwent surgery at the Department of Thoracic Surgery, China-Japan Friendship Hospital, from March 2011 to June 2025. Their underlying diseases, clinical manifestations, preoperative evaluation, surgical procedures, perioperative complications, antifungal therapy, and follow-up outcomes were analyzed. Results  A total of 26 patients were enrolled, including 13 males and 13 females, with a median age of 37 years (interquartile range, 25-47; range, 10-70). Sixteen (61.5%) patients had diabetes mellitus, and 6 (23.1%) had malignancy or hematological diseases. Nineteen (73.1%) patients presented with preoperative hemoptysis. Surgical procedures included lobectomy (n=14, 53.8%), combined lobectomy (n=4, 15.4%), and pneumonectomy (n=8, 30.8%). Five procedures were performed via video-assisted thoracoscopic surgery, with 3 patients requiring conversion to thoracotomy. Postoperative complications occurred in 11 (42.3%) patients. The 30-day, 90-day, and overall follow-up mortality rates were 7.7% (n=2), 11.5% (n=3), and 19.2% (n=5), respectively. Exploratory subgroup analysis revealed that the pneumonectomy group had a larger maximum lesion diameter than the lobectomy group (median, 10.5 cm vs. 4.0 cm; P=0.002) and a higher 90-day mortality rate (37.5% vs. 0.0%; P=0.036). Conclusion  For patients with resectable pulmonary mucormycosis whose condition permits surgery, surgical resection combined with standard antifungal therapy can be an effective treatment strategy. Lobectomy is the primary surgical approach, while pneumonectomy is often performed for conditions such as destroyed lung, hilar involvement, or massive hemoptysis, and requires careful attention to infection control and perioperative multidisciplinary management.

Copyright ? the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved